Tanyeri, P. Et Al. 2013. Evidence that the anxiolytic-like effects of the beta3 receptor agonist Amibegron involve serotoninergic receptor activity. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , vol.110 , 27-32.

Tanyeri, P., Buyukokuroglu, M. E., Mutlu, O., Ulak, G., Akar, F., Celikyurt, I. K., ... Erden, B. F.(2013). Evidence that the anxiolytic-like effects of the beta3 receptor agonist Amibegron involve serotoninergic receptor activity. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , vol.110, 27-32.

Tanyeri, Pelin Et Al. "Evidence that the anxiolytic-like effects of the beta3 receptor agonist Amibegron involve serotoninergic receptor activity," PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , vol.110, 27-32, 2013

Tanyeri, Pelin Et Al. "Evidence that the anxiolytic-like effects of the beta3 receptor agonist Amibegron involve serotoninergic receptor activity." PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , vol.110, pp.27-32, 2013

Tanyeri, P. Et Al. (2013) . "Evidence that the anxiolytic-like effects of the beta3 receptor agonist Amibegron involve serotoninergic receptor activity." PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , vol.110, pp.27-32.

@article{article, author={Pelin Tanyeri Et Al. }, title={Evidence that the anxiolytic-like effects of the beta3 receptor agonist Amibegron involve serotoninergic receptor activity}, journal={PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR}, year=2013, pages={27-32} }